What's breaking now, across thousands of outlets.
(RTTNews) - Natera, Inc. (NTRA), a clinical genetic testing company announced on Thursday that it will collaborate with privately held Angiex, Inc., to use its Signatera test for circulating tumor DNA monitoring in a Phase I study of AGX101, an investigational nuclear-delivered a
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
A big glass of moo juice — no, make that several glasses a day — is common in Rwanda. Is that too much of a good thing?
[Daily News] Ethiopia -- TANZANIA has supported ongoing efforts to strengthen the World Health Organisation (WHO) through reforms of the global health architecture, while stressing the need to…
The Ghana Medical Trust Fund (GMTF) has signed a Memorandum of Understanding (MOU) with the Sweden Ghana Medical Centre to expand access to specialised healthcare, particularly cancer diagnosis and…
Veteran Nollywood actor, Musiliu Dasofunjo, better known as Baba Johunomi, has spoken up about his battle with prostate cancer.
The true impact of missing doses of blood pressure-lowering medication will be demonstrated in a presentation at ESC Congress 2026.
We want to have a conversation about human papillomavirus (HPV), starting with 7 questions about HPV people frequently ask our Cancer Research UK nurses.
